Evidence map›Paper›PMID 18596164›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2008

Separate proteolipid protein/DM20 enhancers serve different lineages and stages of development.

Maria Clarita Tuason, Ali Rastikerdar, Tanja Kuhlmann, Cécile Goujet-Zalc, Bernard Zalc, Samar Dib, Hana Friedman, Alan Peterson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Frontiers in cellular neuroscience · 2023
    Article
  2. Frontiers in cellular neuroscience · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Early postnatal proteolipid promoter-expressing progenitors produce multilineage cells in vivo.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Maria Clarita TuasonMolecular Oncology Group, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.
Ali Rastikerdar
Tanja Kuhlmann
Cécile Goujet-Zalc
Bernard Zalc
Samar Dib
Hana Friedman
Alan Peterson
Royal Victoria Hospital · CACentre National de la Recherche Scientifique · FRInserm · FRInstitut du Cerveau · FRUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gene encoding DM20 emerged in cartilaginous fish, descending from a bilaterian ancestor of the M6 proteolipid gene family. Its proteolipid protein (PLP) isoform appeared in amphibians, contains an additional 35 amino acids, and, in the mammalian CNS, is the dominant myelin protein in which it confers an essential neuroprotective function. During development, the DM20 isoform is prominent in a number of tissues, and plp/DM20 transcripts are detected in multiple progenitor populations, including those that continue to express plp/DM20 as they differentiate into myelinating oligodendrocytes. The locus also encodes isoforms with extended leader sequences that accumulate in the cell bodies of several types of neurons. Here, to locate and characterize regulatory sequences controlling the complex plp/DM20 transcription program, putative regulatory sequences, suggested by interspecies conservation, were ligated individually to a minimally promoted eGFPlacZ reporter gene. These constructs were inserted in single copy at a common site adjacent to the hypoxanthine-guanine phosphoribosyltransferase locus in embryonic stem cells and their in vivo expression programs were compared in transgenic mice. Most expressed developmental and cell-specific subprograms accommodated within the known expression phenotype of the endogenous plp/DM20 locus, thus defining multiple components of the combinatorial mechanism controlling its normal temporal and cell-specific program. Along with previously characterized nervous system enhancers, those described here should help expose the content and configuration of elements that are operational in multiple glial and neuronal lineages. The transgenic lines derived here also provide effective markers for multiple stages of glial and neuronal lineage progression.

Indexed as

AnimalsCell DifferentiationCell LineageEmbryonic Stem CellsEnhancer Elements, GeneticEvolution, MolecularFemaleGene Expression Regulation, DevelopmentalGenes, ReporterHypoxanthine PhosphoribosyltransferaseMaleMiceMice, TransgenicMyelin Proteolipid ProteinNervous SystemNeurogliaHypoxanthine PhosphoribosyltransferaseMyelin Proteolipid ProteinPlp1 protein, mouse

Identifiers

PMID18596164
PMCPMC6670966
OpenAlexW2084302392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.